ATE308974T1 - Anaesthetische propofol zubereitungen - Google Patents

Anaesthetische propofol zubereitungen

Info

Publication number
ATE308974T1
ATE308974T1 AT02755248T AT02755248T ATE308974T1 AT E308974 T1 ATE308974 T1 AT E308974T1 AT 02755248 T AT02755248 T AT 02755248T AT 02755248 T AT02755248 T AT 02755248T AT E308974 T1 ATE308974 T1 AT E308974T1
Authority
AT
Austria
Prior art keywords
preparations
propofol preparations
anaesthetic
anaesthetic propofol
anaesthctic
Prior art date
Application number
AT02755248T
Other languages
English (en)
Inventor
John Meadows
Road Gwilym
Simon Higginbottom
Original Assignee
Maelor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Pharmaceuticals Ltd filed Critical Maelor Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE308974T1 publication Critical patent/ATE308974T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02755248T 2001-08-24 2002-08-23 Anaesthetische propofol zubereitungen ATE308974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120702.6A GB0120702D0 (en) 2001-08-24 2001-08-24 Anaesthetic formulations
PCT/GB2002/003911 WO2003017977A1 (en) 2001-08-24 2002-08-23 Anaesthetic formulations of propofol

Publications (1)

Publication Number Publication Date
ATE308974T1 true ATE308974T1 (de) 2005-11-15

Family

ID=9920994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02755248T ATE308974T1 (de) 2001-08-24 2002-08-23 Anaesthetische propofol zubereitungen

Country Status (6)

Country Link
US (1) US20040253277A1 (de)
EP (1) EP1418891B1 (de)
AT (1) ATE308974T1 (de)
DE (1) DE60207266D1 (de)
GB (1) GB0120702D0 (de)
WO (1) WO2003017977A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494297C (en) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
TR200801336T1 (tr) 2005-08-31 2008-08-21 Abraxis Bioscience, Inc. Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
EP2034906A4 (de) * 2006-06-21 2010-07-28 Univ Leland Stanford Junior Zusammensetzungen und verfahren zur verbindung nicht untereinander verbundener lumen
US8608760B2 (en) * 2006-06-21 2013-12-17 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8197499B2 (en) * 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
CA2708761C (en) * 2007-12-17 2015-04-14 The Regents Of The University Of Michigan Compositions and methods for treating and preventing skeletal muscle deficiencies
WO2009086206A2 (en) * 2007-12-20 2009-07-09 Synvascular, Inc. Compositions and methods for joining non-conjoined lumens
US8563037B2 (en) * 2009-02-06 2013-10-22 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
WO2011066201A2 (en) * 2009-11-25 2011-06-03 The Regents Of The University Of Michigan Methods and systems for treating and preventing cardiac injury in dystrophic subjects
SI2552487T1 (sl) 2010-04-01 2017-02-28 Pharmanest Ab Termo-gelirni anestetski sestavki
CN114073675A (zh) * 2020-08-10 2022-02-22 复旦大学 一种丙泊酚混合胶束及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
ES2261210T3 (es) * 1999-06-21 2006-11-16 Kuhnil Pharmaceutical Co., Ltd. Comoposicion anestesica para inyeccion intravenosa que comprende propofol.
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
AU6689601A (en) * 2000-06-16 2002-01-02 Rtp Pharma Inc Improved injectable dispersions of propofol

Also Published As

Publication number Publication date
EP1418891B1 (de) 2005-11-09
WO2003017977A1 (en) 2003-03-06
GB0120702D0 (en) 2001-10-17
DE60207266D1 (de) 2005-12-15
EP1418891A1 (de) 2004-05-19
US20040253277A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE308974T1 (de) Anaesthetische propofol zubereitungen
GB2359747B (en) Anaesthetic formulations
NO20024309D0 (no) Intradermal penetreringsmidler for topikal lokal anestetisk administrering
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
YU29901A (sh) Primena dialkil fumarata
MA23415A1 (fr) Shampoings a fort pouvoir moussant et a forte teneur en depot avec systeme tensioactif doux.
UA82979C2 (ru) Фармацевтическая композиция, пригодная для перорального введения, которая содержит no-высвобождающие нспвл, лекарственная форма, фармацевтическая комбинация и способы лечения
ES2101578T3 (es) Agente analgesico y su utilizacion.
DE69716271T2 (de) Zusammensetzungen enthaltend lidocain und emu-öl und verwendungsmethoden
IT1275595B1 (it) Tiristore a tre terminali con caratteristiche controllate a gate o porta mos singola
DE69928815D1 (de) Dosierungsform mit flüssiger formulierung
ATE314084T1 (de) Kahalalid f formulierung
DK1217999T3 (da) Anvendelse af baclofen til behandling af alkoholisme
BR9709316A (pt) Composição farmacêutica para administração tópica no tratamento da vaginite
DK1063981T3 (da) Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
ATA18952001A (de) Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
ES2126760T3 (es) Nuevo ansiolitico.
Farnell Plains Indian sign-talk: Action and discourse among the Nakota (Assiniboine) people of Montana
张建慧 My Bracelet
Lipten Merit, morality, and money at the Taipei Palace of the Saintly Emperor
Tvordi Public displays of private desires: representations of female homoeroticism on the Elizabethan stage
TR200100414A2 (tr) Parasetamol yeni enjekte edilebilir çözeltileri ve aktif farmasötik maddeler ile kombinasyon halindeki enjekte edilebilir çözeltileri
Etter Jr Working people, working spirits: person, power, and poetry in a Brazilian religion of spirit possession
Shuzhong Brief iutroduction on the success of captvie breeding of rare birds in the Beijing Zoo
UA31754A (uk) Спосіб профілактики рецидивів меланоми шкіри

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties